Johnson & Johnson vaccine could be approved by mid-March

Ireland would be entitled to 2.2 million doses of the single-shot vaccine

Daniel Murray

Political Correspondent @danieltmurray
16th February, 2021
Johnson & Johnson vaccine could be approved by mid-March
The new vaccine, developed by Johnson & Johnson subsidiary Janssen, would be the fourth vaccine available in Europe. Picture: Getty

A new Covid-19 vaccine from Johnson & Johnson could be approved in Europe as early as mid-March following an application for authorisation to the European Medicines Agency (EMA) on Tuesday.

The new vaccine, developed by Johnson & Johnson subsidiary Janssen, would be the fourth vaccine available in Europe, but the first one that requires just a single dose.

The European Commission has ordered 200 million doses of the vaccine, of which Ireland will be entitled...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Related Stories

Covid-19: an endless marathon, not a sprint

Dan O’Brien: Covid-19 has brought out the inner catastrophist in our national psyche

Freedom day postponed in favour of a step towards normality

Government hopes to raise vaccination rates via passports for pubs and restaurants